Huanling Zhu

5PUBLICATIONS
29CO-AUTHORS
Medical biotechnology diagnostics (incl. biosensors)Molecular medicineMolecular targetsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Medical mycology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Oct 10, 2025
Performance of Large Language Models in Diagnosing Rare Hematologic Diseases and the Impact of Their Diagnostic Outputs on Physicians: Combined Retrospective and Prospective Study.

Hongbin Yu, Tian Chen, Xin Zhang

|Feb 12, 2024
Efficacy, safety, and survival findings after long-term follow-up of ZGJAK002: A phase 2 study comparing jaktinib at 100 mg twice daily (BID) and 200 mg once daily (QD) in patients with myelofibrosis.

Yi Zhang, Hu Zhou, Zhongxing Jiang

|Jul 20, 2023
Safety and efficacy of jaktinib (a novel JAK inhibitor) in patients with myelofibrosis who are intolerant to ruxolitinib: A single-arm, open-label, phase 2, multicenter study.

Yi Zhang, Hu Zhou, Minghui Duan

|May 02, 2023
Imatinib compared with second-generation tyrosine kinase-inhibitors in persons with chronic myeloid leukemia presenting in accelerated phase.

Sen Yang, Xiaoshuai Zhang, Robert Peter Gale

|Sep 02, 2022
Safety and efficacy of jaktinib in the treatment of Janus kinase inhibitor-naïve patients with myelofibrosis: Results of a phase II trial.

Yi Zhang, Hu Zhou, Zhongxing Jiang

Pageof 1

Frequent Collaborators

3 joint publications

Jianda Hu

3 joint publications

Qian Jiang

3 joint publications

Yi Zhang

3 joint publications

Jie Jin